Internal Medicine, Pulmonary Disease · Beaver, PA
NPI
1114957990
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1000 Dutch Ridge Rd
Beaver, PA, 15009
Phone (724) 773-6403
Groups this clinician bills Medicare through
Medicare paid, 2024
$146K
3,846 services
Medicare patients, 2024
305
Average age 73
Drug cost, 2024
$3.7M
4,114 prescriptions
Company payments, 2025
$77.95
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew E Woodske was code 99214 (office e&m - established), 200 times for 129 patients. In total Matthew E Woodske billed 3,846 services in 44 codes, and Medicare paid $146K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 200 | 129 | $90.02 | $18K |
| 96372 Injection Administration | Office | 121 | 11 | $9.74 | $1,178 |
| 99232 Hospital E&M - Subsequent | Facility | 112 | 62 | $56.99 | $6,383 |
| 99291 Critical Care E&M | Facility | 70 | 30 | $157.27 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 52 | 40 | $84.01 | $4,369 |
| 94729 Pulmonary Function Testing | Facility | 27 | 27 | $6.63 | $179 |
| 99222 Hospital E&M - Initial | Facility | 27 | 27 | $91.52 | $2,471 |
| 99213 Office E&M - Established | Office | 26 | 25 | $65.62 | $1,706 |
| 94726 Pulmonary Function Testing | Facility | 24 | 24 | $8.94 | $215 |
| 94010 Pulmonary Function Testing | Facility | 24 | 24 | $6.11 | $147 |
| 31624 Bronchoscopy | Facility | 22 | 21 | $54.60 | $1,201 |
| 99204 Office E&M - New | Office | 13 | 13 | $125.75 | $1,635 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $112.29 | $1,235 |
| 99215 Office E&M - Established | Office | 11 | 11 | $136.25 | $1,499 |
| 99203 Office E&M - New | Office | 11 | 11 | $51.98 | $572 |
By year: 2022 $69K for 872 services; 2023 $108K for 2,312 services; 2024 $146K for 3,846 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew E Woodske prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 510 prescriptions and refills. In total Matthew E Woodske wrote 4,114 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 510 | 614 | 125 | $382K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 323 | 391 | 67 | $171K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 283 | 327 | 121 | $9,950 |
| Breo Ellipta Fluticasone/Vilanterol | 224 | 268 | 55 | $103K |
| Prednisone Generic | 185 | 230 | 102 | $963 |
| Azithromycin Generic | 171 | 238 | 50 | $3,401 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 160 | 184 | 42 | $112K |
| Fluticasone Propionate Generic | 153 | 215 | 62 | $1,437 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 133 | 171 | 32 | $79K |
| Ventolin Hfa Albuterol Sulfate | 125 | 133 | 49 | $7,691 |
| Montelukast Sodium Generic | 121 | 268 | 43 | $1,579 |
| Famotidine Generic | 118 | 161 | 26 | $1,084 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 86 | 96 | 24 | $18K |
| Omeprazole Generic | 85 | 121 | 24 | $811 |
| Xarelto Rivaroxaban | 79 | 127 | 13 | $68K |
Brand drugs: 2,312 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew E Woodske $77.95 ($77.95 in general payments such as food, travel and fees) from 3 companies. The largest payer was Amgen Inc. with $34.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.